Reaction
Infusion Site Oedema reporting signals
As of the last recalculation, Infusion Site Oedema appears in 818 FAERS reports alongside 19 co-occurring drug terms. The strongest observed disproportionality signal is TREPROSTINIL (PRR 127.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Treprostinil | 356 | 127.0 | 127.4 |
| Human Immunoglobulin G | 35 | 45.0 | 45.1 |
| Iron Sucrose | 15 | 40.8 | 40.8 |
| Tadalafil | 121 | 35.9 | 36.0 |
| Diphenhydramine Hydrochloride Capsule, Liquid Filled | 28 | 34.5 | 34.5 |
| Sildenafil Citrate | 125 | 29.3 | 29.3 |
| Bosentan | 52 | 28.0 | 28.0 |
| Adrenalinum | 42 | 27.1 | 27.1 |
| Ambrisentan | 109 | 25.5 | 25.5 |
| Infliximab-Dyyb | 26 | 23.3 | 23.4 |
| Ketoprofen | 11 | 21.6 | 21.6 |
| Sildenafil Powder, | 29 | 21.5 | 21.5 |
| Macitentan | 51 | 19.9 | 19.9 |
| Epinephrine | 45 | 18.4 | 18.5 |
| Sildenafil | 38 | 17.5 | 17.5 |
| Remdesivir | 9 | 17.4 | 17.4 |
| Riociguat | 19 | 15.2 | 15.2 |
| Bendamustine Hydrochloride | 5 | 10.7 | 10.7 |
| Budesonide, Glycopyrrolate, And Formoterol Fumarate | 3 | 7.3 | 7.3 |